All three trials in the Company’s registrational ECLIPSE program for chronic hepatitis delta (CHD) have now been initiated.

This program aims to connect students and researchers from Indian universities with Indian American faculty at prestigious U.S. institutions and creating a global academic exchange platform.

Best Contact Management Software The best way to track, analyze, and manage your contacts is with CRM software. Here are our top picks for contact management.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the combination of tobevibart ...

The Illinois Family Roots Pilot program is expanding across the state after launching in June with 250 kits. A program aimed at helping Black residents trace their ancestry, and in some cases ...

NetDocuments is aiming to connect with additional legal tech providers for its ndConnect program, which allows users to securely access documents produced by third-party applications.

ECLIPSE 2 is one of three trials in Vir Biotechnology’s registrational ECLIPSE program for CHD, which was initiated in March 2025 .

The company recently enrolled the first participant in its ECLIPSE 2 Phase 3 trial for hepatitis delta virus. In another development, Vir Biotechnology dosed the first patient in a Phase 1 trial ...